Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1468 Records) |
Query Trace: Breast and ovarian cancer [original query] |
---|
Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees. Journal of medical genetics 2023 9 . Mathias Schwartz, Sabrina Ibadioune, Albain Chansavang, Sophie Vacher, Sandrine M Caputo, Hélène Delhomelle, Jennifer Wong, Khadija Abidallah, Virginie Moncoutier, Véronique Becette, Tatiana Popova, Voreak Suybeng, Antoine De Pauw, Marc-Henri Stern, Chrystelle Colas, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Lisa Golmard, Ivan Bieche, Julien Masliah-Planch |
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer. Oncology and therapy 2023 9 . Hamdy A Azim, Samah A Loutfy, Hatem A Azim, Nermin S Kamal, Nasra F Abdel Fattah, Mostafa H Elberry, Mohamed R Abdelaziz, Marwa Abdelsalam, Madonna Aziz, Kyrillus S Shohdy, Loay Kass |
Factors associated with adherence to BRCA1/2 mutation testing after oncogenetic counseling in long-surviving patients with a previous diagnosis of breast or ovarian cancer. Journal of community genetics 2023 9 . Silvia Actis, Marta D'Alonzo, Luca Pace, Serena Mucciacito, Valentina Elisabetta Bounous, Luca Giuseppe Sgrò, Matteo Mancarella, Annamaria Ferrero, Nicoletta Bigl |
Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer. Cancers 2023 12 15 (23): . Pedro Antunes Meireles, Sofia Fragoso, Teresa Duarte, Sidónia Santos, Catarina Bexiga, Priscila Nejo, Ana Luís, Beatriz Mira, Isália Miguel, Paula Rodrigues, Fátima V |
Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations. Clinica chimica acta; international journal of clinical chemistry 2023 12 552 117695. Mar Infante, Mónica Arranz-Ledo, Enrique Lastra, Amaya Olaverri, Raquel Ferreira, Marta Orozco, Lara Hernández, Noemí Martínez, Mercedes Dur |
A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family. The oncologist 2023 12 . Xiling Yang, Li Shang, Liren Yang, Landi Sun, Xiaoqian Tuo, Sijia Ma, Le Zhao, Xu Li, Wenfang Ya |
Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome. Cancers 2023 12 15 (24): . Pavlina Chrysafi, Chinmay T Jani, Margaret Lotz, Omar Al Omari, Harpreet Singh, Katherine Stafford, Lipisha Agarwal, Arashdeep Rupal, Abdul Qadir Dar, Abby Dangelo, Prudence L |
Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia. Advances in laboratory medicine 2023 12 4 (3): 279-287. Laura Rosado-Jiménez, Younes Mestre-Terkemani, Ángeles García-Aliaga, Miguel Marín-Vera, José Antonio Macías-Cerrolaza, María Desamparados Sarabia-Meseguer, María Rosario García-Hernández, Marta Zafra-Poves, Pilar Sánchez-Henarejos, Francisco Ayala de la Peña, José Luis Alonso-Romero, José Antonio Noguera-Velasco, Francisco Ruiz-Espe |
Do testosterone and sex hormone-binding globulin affect cancer risk? A Mendelian randomization and bioinformatics study. The aging male : the official journal of the International Society for the Study of the Aging Male 2023 11 26 (1): 2261524. Xiwen Liu, Lixuan Lin, Qi Cai, Caichen Li, Haoxiang Xu, Ruiqi Zeng, Mingtong Zhang, Xinyi Qiu, Shiqi Chen, Xizhe Zhang, Linchong Huang, Wenhua Liang, Jianxing |
Association between testosterone and cancers risk in women: a two-sample Mendelian randomization study. Discover. Oncology 2023 11 14 (1): 198. Zhizhou Li, Maoyu Wang, Meimian Hua, Ziwei Wang, Yidie Ying, Zhensheng Zhang, Shuxiong Zeng, Huiqing Wang, Chuanliang |
[BRCA2 Mutation Profile in a Proband with Hereditary Breast and Ovarian Cancer-Two Germline Pathogenic Variants Aligned in the Cis Position]. Gan to kagaku ryoho. Cancer & chemotherapy 2023 11 50 (10): 1089-1091. Seigo Yukisawa, Toshiyuki Kakinuma, Junko Yotsumoto, Kentaro Kawakami, Junji Furukawa, Hiroharu Shinoza |
Cis - and trans -eQTL TWAS of breast and ovarian cancer identify more than 100 risk associated genes in the BCAC and OCAC consortia. bioRxiv : the preprint server for biology 2023 11 . S Taylor Head, Felipe Dezem, Andrei Todor, Jingjing Yang, Jasmine Plummer, Simon Gayther, Siddhartha Kar, Joellen Schildkraut, Michael P Epste |
The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times. International journal of molecular sciences 2023 11 24 (21): . Paolo Aretini, Silvano Presciuttini, Aldo Pastore, Alvaro Galli, Sara Panepinto, Mariella Tancredi, Matteo Ghilli, Chiara Guglielmi, Diletta Sidoti, Caterina Congregati, Maria Adelaide Cali |
Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience. Hereditary cancer in clinical practice 2023 11 21 (1): 23. Aya Tanaka, Megumi Matsumoto, Mami Takao, Shoko Miura, Yuri Hasegawa, Ryota Otsubo, Hiroko Hayashi, Ichiro Isomoto, Kiyonori Miura, Takeshi Nagaya |
RediScore: Prospective validation of a pipeline for homologous recombination deficiency analysis. Oncology letters 2023 10 26 (5): 480. Aikaterini Tsantikidi, Konstantinos Papazisis, Theofanis Floros, Maria Gazouli, Eirini Papadopoulou, Georgios Tsaousis, Georgios Nasioulas, Andra Mester, Kubelac Paul Milan, Bogdan Gozman, Vlad Afrasanie, Dana Lucia Stanculeanu, Oana Trifanescu, Florentina Pescaru, Claudia Militaru, Christos Papadimitri |
A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer. Breast care (Basel, Switzerland) 2023 10 18 (5): 412-416. Paulina Gebhart, Yen Tan, Daniela Muhr, Christina Stein, Christian Sing |
Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse. Journal of ovarian research 2023 10 16 (1): 209. Yana Ma, Jiale Liu, Ning Li, Hualei Bu, Yongwen Huang, Chengjuan Jin, Hao Wen, Shuai Feng, Hui Zhang, Xiaorong Yang, Beihua Kong, Lingying Wu, Kun So |
Hereditary cancer testing in a diverse sample across three breast imaging centers. Breast cancer research and treatment 2023 10 . Laura Westbrook, Darlene Miltenburg, Vivienne Souter, Melissa K Maisenbacher, Katherine L Howard, Youbao Sha, Maygol Yavari, Nicholas Kypraios, Angel Rodriguez, Jeffrey N Weitz |
Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus. Breast cancer research and treatment 2023 10 . Anna P Sokolenko, Elvina Kh Bakaeva, Aigul R Venina, Ekaterina Sh Kuligina, Alexandr A Romanko, Svetlana N Aleksakhina, Yana V Belysheva, Evgeniya V Belogubova, Ilya A Stepanov, Olga A Zaitseva, Olga S Yatsuk, Alexandr V Togo, Zaur M Khamgokov, Azinat O Kadyrova, Albert Sh Pirmagomedov, Marina B Bolieva, Alexandr A Epkhiev, Aslan K Tsutsaev, Madina D Chakhieva, Khalimat M Khabrieva, Idris M Khabriev, Mirza A Murachuev, Bella N Buttaeva, Liliya S Baboshkina, Fatima I Bayramkulova, Islam R Katchiev, Lina Kh Alieva, Grigory A Raskin, Sergey V Orlov, Zarema K Khachmamuk, Karine R Levonyan, Dariya M Gichko, Dmitriy V Kirtbaya, Alexey M Degtyariov, Luisa V Sultanova, Hedi S Musayeva, Alexey M Belyaev, Evgeny N Imyanit |
The causal association between artificial sweeteners and the risk of cancer: a Mendelian randomization study. Food & function 2024 4 . Haotian Pan, Chenchen Feng, Ziting Zhou, Jiamin Huang, Jiasi Deng, Yuanyuan Zhou, Yuxuan Wang, Xinru Mu, Qian Wang, Ke Wang, Zhigang |
Variants in BRCA1/2 in a hospital-based cohort in Chile and national literature review. Ecancermedicalscience 2024 4 18 1683. Fernanda J Martin, Isabel M Saffie, Mabel A Hurtado, Diana Avila-Jaque, Rodrigo A Lagos, Carolina A Selman, Jonathan Z Huserman, Valentina A Castillo, Badir J Chahu |
A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants. Clinical laboratory 2024 4 70 (4): . Jin Ju Kim, Dong Ja Kim, Eon Jeong Nam, Kyung Eun Song, Ji Yeon Ham, Yu Kyung Kim, Nan Young L |
Combinational use of trabectedin and pegylated liposomal doxorubicin for recurrent ovarian cancer: a meta-analysis of phase III randomized controlled trials. American journal of translational research 2024 1 15 (12): 6675-6689. Chao Li, Siyi Qiao, Min Kang, Xiaofeng Gao, Zhiru |
Optical Genome Mapping Reveals the Landscape of Structural Variations and Their Clinical Significance in HBOC-Related Breast Cancer. Frontiers in bioscience (Landmark edition) 2024 1 29 (1): 2. Yanan Cheng, Li Dong, Dechao Bu, Lei Han, Yi Zhao, Juntian Liu, Xiaojing Guo, Hanli Xu, Jinpu |
Benzo[a]pyrene exposure affects colorectal cancer susceptibility by regulating ER?-mediated LINC02977 transcription. Environment international 2024 1 184 108443. Shuai Ben, Shuwei Li, Dongying Gu, Lingyan Zhao, Shenya Xu, Zhutao Ding, Silu Chen, Yifei Cheng, Junyi Xin, Mulong Du, Meilin Wa |
A real-world study of PARP inhibitors in 75 patients with platinum-sensitive recurrent ovarian cancer from China. Frontiers in oncology 2024 1 13 1300199. Jinghong Chen, Mengpei Zhang, Kemin Li, Yuanqiong Duan, Xiaojuan Lin, Lan Zhong, Qintong Li, Rutie Y |
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 2024 1 . Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Lingying Wu, Hongwen Y |
BRCA mutation patients: are there other predisposing factors for ovarian cancer occurrence? A multicentre retrospective study. Gynecologic and obstetric investigation 2024 1 . Vera Loizzi, Michele Mongelli, Francesca Arezzo, Isabella Romagno, Gerardo Cazzato, Ondina Popescu, Francesco Legge, Paolo Trerotoli, Erica Silvestris, Anila Kardhashi, Gennaro Corm |
BRCA2, PALB2, RECQL4 Germline Pathogenic Variants, and Somatic TP53 Mutation in Triple Metachronous Malignancies: A Case Report and Literature Review. International medical case reports journal 2024 1 17 23-29. Yang Liu, Hui Yang, Xueshu Fu, Luting Zhong, Ping Xu, Fang Fang, Ying Liu, Qing Li, Ya'nan Yan, Shanchuang Wei, Junqing Wang, Chunhua Zha |
Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology, research and practice 2024 1 254 155075. Seref Bugra Tuncer, Betul Celik, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Busra Kurt Gültaslar, Demet Akdeniz Odemis, Mukaddes Avsar, Fatma Sen, P?nar Mualla Saip, Hulya Yazi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: